Skip to main content
. 2017 Apr 24;2017(4):CD010285. doi: 10.1002/14651858.CD010285.pub2

Analysis 3.2.

Analysis 3.2

Comparison 3 Regimens containing nitroimidazoles versus no nitroimidazoles, Outcome 2 Sensitivity analysis by risk of bias: effectiveness of cure in mild‐moderate PID.